Gemfibrozil Tablet, Film Coated
Product Images NDC 16571-784

2 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Gemfibrozil (NDC 16571-784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (600 mg (60 Tablet Bottle))

Package Label-principal Display Panel (600 mg (60 Tablet Bottle))
Gemfibrozil Tablets, USP 600 mg film-coated tablets label from Rising Pharma Holdings, Inc. The package contains 60 tablets for oral use. The label includes storage instructions to keep the tablets at 20° to 25°C and advises protection from light and humidity. The product is distributed by Rising Pharma Holdings, Inc., made in India, with an NDC of 16571-784-06.*
FDA Label Image

Chemical Structure (Gemfibrozil Str)

Chemical Structure (Gemfibrozil Str)
Chemical structure of gemfibrozil, showing its molecular arrangement with a methyl-substituted phenyl ring connected to a propanoic acid side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.